journal article·2023-01Open access

Cilia‐Mediated Insulin/Akt and ST2/JNK Signaling Pathways Regulate the Recovery of Muscle Injury

Daishi Yamakawa, Junya Tsuboi, Kousuke Kasahara, Chise Matsuda, Yuhei Nishimura, Tatsuya Kodama, Naoyuki Katayama, Masatoshi Watanabe, Masaki Inagaki

Advanced Science· Volume 10· Issue 1

Abstract

Abstract Following injury, skeletal muscle regenerates but fatty tissue accumulation is seen in aged muscle or muscular dystrophies. Fibro/adipogenic progenitors (FAPs) are key players in these events; however, the effect of primary cilia on FAPs remains unclear. Here, it is reported that genetic ablation of trichoplein (TCHP), a ciliary regulator, induces ciliary elongation on FAPs after injury, which promotes muscle regeneration while inhibiting adipogenesis. The defective adipogenic differentiation of FAPs is attributed to dysfunction of cilia‐dependent lipid raft dynamics, which is critical for insulin/Akt signaling. It is also found that interleukin (IL) 13 is substantially produced by intramuscular FAPs, which are upregulated by ciliary elongation and contribute to regeneration. Mechanistically, upon injury, long cilia excessively activate the IL33/ST2/JNK axis to enhance IL13 production, facilitating myoblast proliferation and M2 macrophage polarization. The results indicate that FAPs organize the regenerative responses to skeletal muscle injury via cilia‐mediated insulin/Akt and ST2/JNK signaling pathways.
Source: crossref · Quality: baseline

Research context

OpenAlex topics: Muscle Physiology and Disorders · Mesenchymal stem cell research · Tissue Engineering and Regenerative Medicine

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Department of Physiology Mie University Graduate School of Medicine Tsu Mie 514‐8507 Japan

Department of Gastroenterology and Hepatology Mie University Graduate School of Medicine Tsu Mie 514‐8507 Japan

Department of Hematology and Oncology Mie University Graduate School of Medicine Tsu Mie 514‐8507 Japan

Department of Oncogenic Pathology Mie University Graduate School of Medicine Tsu Mie 514‐8507 Japan

Department of Integrative Pharmacology Mie University Graduate School of Medicine Tsu Mie 514‐8507 Japan

Funding

Takeda Science Foundation · Uehara Memorial Foundation · Naito Foundation · Nakatomi Foundation

References (55)

Show source-provided references
1. 10.1152/physrev.00019.200310.1152/physrev.00019.2003 ↗
2. 10.1016/j.cell.2005.05.01010.1016/j.cell.2005.05.010 ↗
3. 10.1016/j.tcb.2005.10.00710.1016/j.tcb.2005.10.007 ↗
4. 10.1016/j.semcdb.2021.05.03110.1016/j.semcdb.2021.05.031 ↗
5. 10.1084/jem.2007007510.1084/jem.20070075 ↗
6. 10.1038/embor.2013.18210.1038/embor.2013.182 ↗
7. 10.1038/ncb201410.1038/ncb2014 ↗
8. 10.1038/ncb201510.1038/ncb2015 ↗
9. 10.1002/emmm.20120209610.1002/emmm.201202096 ↗
10. 10.1002/stem.108210.1002/stem.1082 ↗
11. 10.1016/j.immuni.2016.01.00910.1016/j.immuni.2016.01.009 ↗
12. 10.1111/imr.1261910.1111/imr.12619 ↗
13. 10.1016/j.cell.2013.10.05410.1016/j.cell.2013.10.054 ↗
14. 10.1016/j.celrep.2019.04.07410.1016/j.celrep.2019.04.074 ↗
15. 10.1084/jem.2012234410.1084/jem.20122344 ↗
16. 10.1007/s12603-010-0081-210.1007/s12603-010-0081-2 ↗
17. 10.1002/mus.1043510.1002/mus.10435 ↗
18. 10.1016/j.ajpath.2014.02.00510.1016/j.ajpath.2014.02.005 ↗
19. 10.1016/j.cell.2017.06.03510.1016/j.cell.2017.06.035 ↗
20. 10.1016/j.cell.2009.10.03610.1016/j.cell.2009.10.036 ↗
21. 10.1016/j.cmet.2012.08.00510.1016/j.cmet.2012.08.005 ↗
22. 10.1242/jcs.04627610.1242/jcs.046276 ↗
23. 10.1083/jcb.20110610110.1083/jcb.201106101 ↗
24. 10.1038/ncomms608110.1038/ncomms6081 ↗
25. 10.1083/jcb.20150704610.1083/jcb.201507046 ↗
26. 10.1016/j.tcb.2021.07.00910.1016/j.tcb.2021.07.009 ↗
27. 10.1016/j.celrep.2021.10881710.1016/j.celrep.2021.108817 ↗
28. 10.1098/rsob.21013010.1098/rsob.210130 ↗
29. 10.1016/j.bbrc.2010.05.02110.1016/j.bbrc.2010.05.021 ↗
30. 10.1016/j.devcel.2018.06.01810.1016/j.devcel.2018.06.018 ↗
31. 10.1038/s41598-019-39538-y10.1038/s41598-019-39538-y ↗
32. 10.1098/rsob.21011010.1098/rsob.210110 ↗
33. 10.3389/fphys.2019.0107410.3389/fphys.2019.01074 ↗
34. 10.1186/s12964-018-0251-010.1186/s12964-018-0251-0 ↗
35. 10.1038/s41418-020-0551-y10.1038/s41418-020-0551-y ↗
36. 10.1146/annurev.immunol.021908.13253210.1146/annurev.immunol.021908.132532 ↗
37. 10.1146/annurev-immunol-032712-09590610.1146/annurev-immunol-032712-095906 ↗
38. 10.4049/jimmunol.174.2.106310.4049/jimmunol.174.2.1063 ↗
39. 10.1038/nature1104710.1038/nature11047 ↗
40. 10.1016/j.immuni.2021.09.01010.1016/j.immuni.2021.09.010 ↗
41. Liu Q. · JCI Insight · 2019 · 4
42. 10.1111/all.1259310.1111/all.12593 ↗
43. 10.1016/j.cell.2013.02.05310.1016/j.cell.2013.02.053 ↗
44. 10.1016/j.immuni.2005.09.01510.1016/j.immuni.2005.09.015 ↗
45. 10.1016/j.biomaterials.2014.02.01210.1016/j.biomaterials.2014.02.012 ↗
46. 10.1016/j.ajpath.2013.01.01710.1016/j.ajpath.2013.01.017 ↗
47. 10.1016/j.xpro.2020.10024610.1016/j.xpro.2020.100246 ↗
48. 10.1016/B978-0-12-417028-5.00006-510.1016/B978-0-12-417028-5.00006-5 ↗
49. Pasut A. · J. Vis. Exp. · 2013 · 22
50. 10.1101/gad.136490610.1101/gad.1364906 ↗
51. 10.1093/hmg/ddi47910.1093/hmg/ddi479 ↗
52. 10.1016/j.diff.2011.11.01510.1016/j.diff.2011.11.015 ↗
53. 10.1101/sqb.2002.67.50710.1101/sqb.2002.67.507 ↗
54. 10.4049/jimmunol.090157510.4049/jimmunol.0901575 ↗
55. 10.1002/hep4.129510.1002/hep4.1295 ↗